ABRE is designed to help identify emerging biological and supply chain risk signals before they become major operational disruptions. By integrating authorized indicators from public health, animal health, agriculture, environmental, logistics, and pharmaceutical supply chain sources, ABRE seeks to support earlier awareness of potential threats and provide decision-makers with more time to prepare, respond, and reduce downstream impacts.
ABRE delivers enabled predictive modeling and analytical workflows to assess how biological threats, agriculture disruptions, and supply chain constraints may evolve over time. These models are intended to help forecast potential impacts on medical countermeasure demand, pharmaceutical availability, food supply continuity, healthcare readiness, and broader national resilience.

ABRE is being developed to simulate how emerging threats may cascade across interconnected systems. Scenario modeling can help users evaluate potential outbreak spread, supply chain stress, livestock or food-system disruption, medical demand surges, and operational readiness impacts under different conditions. This capability is designed to support planning, tabletop exercises, and more informed preparedness decisions.

ABRE is designed to support visibility into critical supply chain vulnerabilities affecting pharmaceuticals, medical countermeasures, food systems, agriculture, and logistics. The platform can be configured to help model shortages, regional disruptions, demand surges, critical input exposure, and potential mitigation options so stakeholders can better understand where resilience gaps may exist.

ABRE is intended to translate complex, multi-domain signals into actionable decision-support outputs, including dashboards, risk scores, alerts, forecasts, scenario models, and preparedness insights. The goal is not to replace human judgment or existing response authorities, but to improve situational awareness and support faster, better-informed decisions by authorized user
ABRE is designed for mission-specific deployment rather than one-size-fits-all implementation. Each deployment can be configured around the customer’s mission, data rights, security requirements, user roles, operational workflows, and reporting needs. This allows ABRE to support different mission areas while maintaining separation, control, and governance over each environment.
Copyright © 2026 USAPI Pharma, PBC. All Rights Reserved. USAPI Pharma, PBC develops ABRE™, a biosecurity intelligence infrastructure platform focused on national readiness, human and animal health security, food supply defense, and pharmaceutical supply chain resilience.. Information on this site is for general informational purposes only and does not imply or constitute any partnership, approval, or endorsement by the U.S. Government or its agencies. Unauthorized reproduction or distribution is prohibited.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.